Pomalidomide Interactions
There are 395 drugs known to interact with pomalidomide, along with 7 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 91 are major, and 304 are moderate.
- View all 395 medications that may interact with pomalidomide
- View pomalidomide alcohol/food interactions (1)
- View pomalidomide disease interactions (7)
Most frequently checked interactions
View interaction reports for pomalidomide and the medicines listed below.
- Acetylsalicylic Acid (aspirin)
- Aspirin Low Strength (aspirin)
- Co-trimoxazole (sulfamethoxazole / trimethoprim)
- Darzalex (daratumumab)
- Dexamethasone Intensol (dexamethasone)
- Eliquis (apixaban)
- Fish Oil (omega-3 polyunsaturated fatty acids)
- Humalog KwikPen (insulin lispro)
- Iron Sulfate (ferrous sulfate)
- Keppra (levetiracetam)
- Klor-Con M20 (potassium chloride)
- Kyprolis (carfilzomib)
- Lasix (furosemide)
- Lidocaine Viscous (lidocaine topical)
- Lyrica (pregabalin)
- Metamucil (psyllium)
- Metoprolol Succinate ER (metoprolol)
- MiraLAX (polyethylene glycol 3350)
- Ninlaro (ixazomib)
- OxyContin (oxycodone)
- Paracetamol (acetaminophen)
- Paxlovid (nirmatrelvir / ritonavir)
- Plavix (clopidogrel)
- Probiotic Formula (bifidobacterium infantis / lactobacillus acidophilus)
- Quercetin (bioflavonoids)
- Revlimid (lenalidomide)
- Velcade (bortezomib)
- Vitamin B12 (cyanocobalamin)
- Vitamin D3 (cholecalciferol)
- Zometa (zoledronic acid)
Pomalidomide alcohol/food interactions
There is 1 alcohol/food interaction with pomalidomide.
Pomalidomide disease interactions
There are 7 disease interactions with pomalidomide which include:
- thromboembolism
- hematologic toxicities
- hepatic impairment
- neuropathy
- renal impairment
- smoking
- tumor lysis syndrome
Report options
More about pomalidomide
- pomalidomide consumer information
- Compare alternatives
- Reviews (3)
- Side effects
- Dosage information
- During pregnancy
- Drug class: miscellaneous antineoplastics
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Abecma
Abecma is a CAR T cell therapy used to treat relapsed refractory multiple myeloma (RRMM); it is a ...
Tecvayli
Tecvayli (teclistamab) is a treatment for relapsed or refractory multiple myeloma. Includes ...
Carvykti
Carvykti (ciltacabtagene autoleucel) is a treatment for relapsed or refractory multiple myeloma ...
Talvey
Talvey is used to treat relapsed or refractory multiple myeloma. Includes Talvey side effects ...
Decadron
Decadron is used for addison's disease, adrenal insufficiency, adrenocortical insufficiency ...
Revlimid
Revlimid is used to treat types of multiple myeloma, mantle cell lymphoma, follicular lymphoma and ...
Taxol
Taxol (paclitaxel) is used to treat breast cancer, lung cancer, and ovarian cancer. Includes Taxol ...
Darzalex
Darzalex (daratumumab) is a target therapy used to treat multiple myeloma. Includes DARZALEX uses ...
Velcade
Velcade injection is used to treat multiple myeloma and mantle cell lymphoma. Includes Velcade side ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
